Levy et al demonstrated activity of the selective AKT inhibitor GSK690693 in a proportion of ALL cell lines [45], but the failure to affect all cell lines, including those of the B lineage, suggest that AKT is not essential for ALL cell proliferation and survival. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.